|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
53212587
???header.onlineuser??? :
1036
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"po han lin"???jsp.browse.items-by-author.description???
Showing items 21-30 of 47 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
Chiang Y.-C.; PO-HAN LIN; Lu T.-P.; Kuo K.-T.; Tai Y.-J.; Hsu H.-C.; Wu C.-Y.; Lee C.-Y.; Shen H.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
|
Chiang Y.-C.; PO-HAN LIN; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:33Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2021-12-14T23:12:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang, Ming Yang; Lo, Chiao; Tsai, Li Wei; Yen, Tzu Chun; Huang, Thomas Yoyan; Huang, Wei Chih; Yang, Karen; Chen, Chih Kai; Fan, Sheng Chih; SUNG-HSIN KUO; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-10-21T23:28:15Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
YING-CHENG CHIANG; PO-HAN LIN; TZU-PIN LU; KUAN-TING KUO; YI-JOU TAI; Hsu, Heng Cheng; Wu, Chia Ying; Lee, Chia Yi; Shen, Hung; CHI-AN CHEN; WEN-FANG CHENG |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
Showing items 21-30 of 47 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
